Top

Annals of General Psychiatry

Published in:

Open Access 01-12-2018 | Primary research

Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit

Authors: Rajnish Mago, Andrea Fagiolini, Emmanuelle Weiller, Catherine Weiss

Published in: Annals of General Psychiatry | Issue 1/2018

Abstract

Background

Despite the availability of effective antidepressants, about half of patients with major depressive disorder (MDD) display an inadequate response to their initial treatment. A large patient survey recently reported that 29.8% of MDD patients experiencing an inadequate treatment response felt frustrated about their medication and 19.2% were frustrated with their healthcare provider. This survey and chart audit evaluated healthcare professionals’ (HCP) views on the emotional impact of having an inadequate response to antidepressant medication.

Methods

HCPs who frequently treat patients with MDD completed a survey and chart audit of their MDD patients currently experiencing an inadequate response to antidepressant treatment.

Results

287 HCPs completed 1336 chart audits. HCPs reported that 38% of their patients were trusting/accepting of their MDD medications and 41% of their patients trusted/felt confident with their healthcare provision. Conversely, HCPs reported that 11% of their patients were frustrated with their medication and 5% with their healthcare benefits. HCPs cited impact on daily life (53%) and treatment issues (lack of efficacy and side effects; 50%) as the main drivers for their patients’ feelings of frustration. When HCPs recognized patients’ feelings of frustration, the top concerns of the HCPs were worsening of symptoms (43%) and non-compliance (41%).

Conclusions

This survey and chart audit highlights the emotional burden associated with inadequate responses to MDD treatment in addition to persistent symptoms. Differences between the views of the HCPs and patients are highlighted and suggest that HCPs may underestimate the full impact that having to try numerous medications has on their patients.

Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231–42.CrossRefPubMed

Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.CrossRefPubMed

Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry. 2009;70(Suppl 6):16–25.CrossRefPubMed

Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9):1501–4.CrossRefPubMed

Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171–80.CrossRefPubMed

Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry. 1998;59(11):608–19.CrossRefPubMed

Chang WH, Lee IH, Chen WT, Chen PS, Yang YK, Chen KC. Coexisting geriatric anxiety and depressive disorders may increase the risk of ischemic heart disease mortality—a nationwide longitudinal cohort study. Int J Geriatr Psychiatry. 2017;32(12):e25–33.CrossRefPubMed

Ho C, Jin A, Nyunt MS, Feng L, Ng TP. Mortality rates in major and subthreshold depression: 10-year follow-up of a Singaporean population cohort of older adults. Postgrad Med. 2016;128(7):642–7.CrossRefPubMed

Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, Van Ganse E. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: a population-based cohort study. Respir Med. 2016;117:33–9.CrossRefPubMed

10.

Laursen TM, Musliner KL, Benros ME, Vestergaard M, Munk-Olsen T. Mortality and life expectancy in persons with severe unipolar depression. J Affect Disord. 2016;193:203–7.CrossRefPubMed

11.

Mago R, Fagiolini A, Weiller E, Weiss C. Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder. BMC Psychiatry. 2018;18(1):33.CrossRefPubMedPubMedCentral

12.

Lewis L, Hoofnagle L. Patient perspectives on provider competence: a view from the depression and bipolar support alliance. Adm Policy Ment Health. 2005;32(5–6):497–503.CrossRefPubMed

13.

Sheehan DV. The Anxiety Disease. New York: Scribner’s; 1983.

14.

Anderson C, Roy T. Patient experiences of taking antidepressants for depression: a secondary qualitative analysis. Res Social Adm Pharm. 2013;9(6):884–902.CrossRefPubMed

15.

Buus N, Johannessen H, Stage KB. Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview study. Int J Nurs Stud. 2012;49(10):1220–9.CrossRefPubMed

16.

Battle CL, Uebelacker L, Friedman MA, Cardemil EV, Beevers CG, Miller IW. Treatment goals of depressed outpatients: a qualitative investigation of goals identified by participants in a depression treatment trial. J Psychiatr Pract. 2010;16(6):425–30.CrossRefPubMedPubMedCentral

17.

Dwight-Johnson M, Sherbourne CD, Liao D, Wells KB. Treatment preferences among depressed primary care patients. J Gen Intern Med. 2000;15(8):527–34.CrossRefPubMedPubMedCentral

18.

Ruggeri M, Salvi G, Bonetto C, Lasalvia A, Allevi L, Parabiaghi A, Bertani M, Tansella M. Outcome of patients dropping out from community-based mental health care: a 6-year multiwave follow-up study. Acta Psychiatr Scand. 2007;437:42–52.CrossRef

19.

Locke EA, Latham GP. Building a practically useful theory of goal setting and task motivation: a 35-year Odyssey. Am Psychol. 2002;57(9):705–17.CrossRefPubMed

Title: Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit
Authors: Rajnish Mago
Andrea Fagiolini
Emmanuelle Weiller
Catherine Weiss
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Annals of General Psychiatry / Issue 1/2018
Electronic ISSN: 1744-859X
DOI: https://doi.org/10.1186/s12991-018-0189-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance

Variation in admission rates between psychiatrists on call in a university teaching hospital

The relation between immunologic variables and symptom factors in patients with major depressive disorder

A comparison of three-factor structure models using WISC-III in Greek children with learning disabilities

Psychotic mania as the solitary manifestation of neurosyphilis

Effect of fish oil omega-3 fatty acids on reduction of depressive symptoms among HIV-seropositive pregnant women: a randomized, double-blind controlled trial